Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Excision Followed by Radiofrequency Ablation for Breast Cancer (ABLATE)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by University of Arkansas
Sponsor:
Collaborator:
Angiodynamics, Inc.
Information provided by (Responsible Party):
University of Arkansas
ClinicalTrials.gov Identifier:
NCT01153035
First received: June 24, 2010
Last updated: September 26, 2016
Last verified: September 2016